Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pfizer raises offer for AstraZeneca, sends letter to UK prime minister
8:45 AM MDT | May 2, 2014 | Natasha Alperowicz
Pfizer announced today that it has submitted a revised written proposal to AstraZeneca to combine the two companies. The move follows consultation with major shareholders. Pfizer says it hopes that the increased proposal to £63.1 billion ($106.5 billion), will provide the basis for AstraZeneca to enter into discussions leading to a possible merger. The offer values AstraZeneca at £50/share in cash and stock. Pfizer’s chairman and CEO Ian Read contacted AstraZeneca’s chairman before the announcement, and AstraZeneca has indicated it...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee